-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Intellipharmaceutics International Inc. quarterly Assets, Current history and growth rate from Q4 2015 to Q4 2018.
- Intellipharmaceutics International Inc. Assets, Current for the quarter ending November 30, 2018 was CA$8.72M, a 145% increase year-over-year.
Assets, Current, Quarterly (CAD)
Assets, Current, YoY Quarterly Growth (%)